(Q60563306)
Statements
A Phase 1, First-in-Human, Double-blinded, Randomized, Placebo-controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of an Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Healthy Flavivirus-Naïve and Flavivirus-Primed Subjects (English)
0 references
1 November 2016
0 references
30 October 2018
0 references
75
0 references
18 year
0 references
49 year
0 references